Drugs / DWP16001 Drug C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05465668 | Jul → Aug 2022 | — | Daewoong Pharmaceutical Co. LTD. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DWP16001 Drug C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05465668 ↗ |